March 7, 2019 | Michael Easterling
Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial.
Clinical social workers and the science of caring
April 17, 2019 | Bob Young
Clinical social workers identify sources of distress and teach coping skills to manage the challenges that come with treatment. They also connect patients to community resources for mental health services, as well as financial and transportation assistance.
Combined immunotherapy could tackle advanced cancers
April 15, 2019 | Zen Vuong
City of Hope physician-scientists recently opened two clinical trials to investigate a combination of cytokines and immunotherapy that may be able to transform nearly impossible-to-treat cancer into a disease that can be corralled into remission.
People miss key area of face with sunscreen products, study finds
April 11, 2019 | Samantha Bonar
People commonly miss their eyelids when applying sunscreen or moisturizers containing SPF. This is of concern because this fragile area is prone to skin cancer.
Disney pals entertain pediatric patients during ToyFest
April 8, 2019 | Michael Easterling
The pediatric patients in treatment at City of Hope are unable to go to Disneyland, so on March 14 Disneyland came to them, at the fourth annual winter ToyFest held on City of Hope’s main campus in Duarte, California.
City of Hope to participate in NCI-MATCH clinical trial
April 5, 2019 | City of Hope
City of Hope’s Clinical Molecular Diagnostic Laboratory (CMDL) is participating as a CLIA-Certified/Accredited laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial.
City of Hope awarded $7.5M to develop treatment for rare cancer
April 3, 2019 | Zen Vuong
City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.
City of Hope study finds diabetes A1c test misses most cases
March 28, 2019 | City of Hope
The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.
Researchers detail new findings at 2019 AACR meeting
March 28, 2019 | Zen Vuong
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.
Joanne Mortimer, M.D., named ASCO fellow, recognized for extraordinary service
March 27, 2019 | Samantha Bonar
Joanne Mortimer, M.D., was one of just 25 oncologists nationwide named a fellow of the American Society of Clinical Oncology for 2019. The distinction recognizes ASCO members for their extraordinary volunteer service, dedication and commitment to ASCO.